本報告已在2011年12月29日停止出版。
更改為出版
European Markets for Orthopedic Biomaterials 2012
出版日期 : 2011年12月
商品編碼: 227374
本報告，調查歐洲的整形外科用生物材料市場，並彙整骨頭移植代用骨頭、玻尿酸黏性補給、膝關節軟骨修復市場的各個概要與處置、競爭動向等，由下列摘要形式闡述。
報告摘要
調查方式
第1章 整形外科用生物材料概要
- 骨頭移植的概要
- 變形性關節症以及玻尿酸黏性補給概要
- 膝關節軟骨修復的概要
第2章 歐洲的整形外科用生物材料市場
第3章 骨頭移植代用骨頭市場
第4章 玻尿酸黏性補給市場
第5章 膝關節軟骨修復市場
- 市場概要
- 市場分析
- EU的先進治療醫療產品企劃
- 處置
- 市場預測
- 市場促進因子・阻礙因子
- 競爭分析
附錄A-H
Abstract
The European market for orthopedic biomaterials has been quite dynamic in the
past few years. While procedure volume expansion was limited to some extent by
the global economic crisis, procedural growth will resume as the economy
continues to recover and many patients no longer need to delay treatments. The
market will also continue to be driven by the aging European population,
increasing marketing efforts by manufacturers and distributors to educate both
physicians and patients on the wide variety of biomaterials available, as well
as ongoing innovation by domestically and internationally based companies.
Reimbursement issues will inhibit market growth, however, as some European
governments curb health care spending. Nevertheless, patients and physicians
will continue to trend toward treatments that provide greater convenience,
such as 1-injection hyaluronic acid (HA) viscosupplementation, or demonstrate
important benefits, such as bone graft substitutes (BGS). As the economic
climate improves, the trend toward more expensive alternatives in the BGS, HA
viscosupplementation, and knee cartilage repair markets will further drive
growth in this market. As a result, the European orthopedic biomaterial market
will continue to show considerable and sustained growth throughout the
forecast period.
METHODOLOGY
RESEARCH METHODOLOGY
This report uses a number of methodologies to gather and present data and
analysis. At the outset, a large survey of secondary sources is conducted.
These sources act as the basis for the primary research stage, which builds
and enhances the quantitative and qualitative attributes of the early research.
Secondary sources include
- Government sources:
- Securities and Exchange Commission filings
- Food and Drug Administration and patent filings
- National Center for Health Statistics data
- National Institute for Health and Clinical Excellence
- L' Agence Francaise de Securite Sanitaire des Produits de Sante
- US Census Bureau International Database
- European Medicines Agency
- Orthopedic biomaterial companies:
- Annual reports, product brochures, corporate profiles, etc.
- Internal databases and reports:
- Previous reports on similar/related sources
- General Internet searches, medical literature, and newspaper/magazine
searches:
- Identifying various centers of specialization and articles that might
provide leads for primary research
The secondary research stage builds the foundation for the primary research.
The primary research methodology has four steps:
Step 1: The first step involves an impartial scan of all the
information gathered during the secondary research stage to determine its
utility based on the specific requirements of this report. Each piece of
information is either discarded or marked as high- or low-priority and then
organized appropriately as determined by the structure and sectioning of the
report.
Step 2: At this stage, early assumptions are formed as to the
implications of the information for the various orthopedic biomaterial market
segments. These assumptions are then used to determine hypotheses using both
inductive and deductive approaches. On the quantitative front, these
hypotheses result in full historical and projected market data sets (market
sizes - unit sales, average selling prices [ASPs], and revenues - as well as
market shares).
Step 3: At this stage, the research is in position for its most
important primary phase - expert interviews. Throughout the secondary research
phase, industry and medical experts are identified. These experts are then
contacted by telephone and asked to participate in interviews on recent trends
and developments in the industry. Interviews are either conducted at the time
of the initial call or scheduled at the convenience of the expert. Interview
questions are tailored to the expertise of each particular interviewee,
although in most cases, the most important questions are asked of all experts.
The questions are largely based on the assumptions and hypotheses developed in
Step 2, which are then augmented, discarded, or adjusted based on the views
and positions put forth. Attempts are made, whenever possible, to cross-check
the views of various experts against each other and to reach positions of
consensus on issues and market numbers.
Step 4: The final stage of primary research involves individual and
group analysis by Millennium Research Group. All research results are assessed
and cross-checked thoroughly to determine their validity, relevance, and
weight. From this process, qualitative conclusions are reached and data points
finalized
In this report, Millennium Research Group also validated its hyaluronic acid
viscosupplementation model and assumptions by comparing base-year sales
projections with actual reported sales provided by IMS.
FORECAST METHODOLOGY
In addition to the research methodology outlined above, the following
“bottom-up” methodology is used to develop forecast assumptions
for the report.
A comprehensive breakdown of various orthopedic biomaterial procedures and
unit sales is prepared using data from several sources, including professional
associations, government statistics, and private research/media sources.
Industry experts and practitioners are consulted to ensure accuracy and verify
observed trends. As a cross-check, total industry revenues available through
annual reports and other sources are compared against modeled industry
revenues.
Using the best estimates of industry experts, practitioners, private
research/media sources, and inhouse experts, year-by-year growth rates and
ASPs are applied individually to each subcategory to derive forecasts. These
estimates are cross-checked by industry experts (marketing managers, product
managers, CEOs, etc.) and further refined.
Overall findings are compared against market and procedure forecasts published
by other sources to ensure reasonable estimates.
Table of Contents
TABLE OF CONTENTS
LIST OF FIGURES AND TABLES
EXECUTIVE SUMMARY
METHODOLOGY
1.0 ORTHOPEDIC BIOMATERIALS BACKGROUND
- 1.1 Bone Graft Overview
- 1.1.1 Autografts
- 1.1.2 Nonproprietary Allografts
- 1.1.3 Demineralized Bone Matrices
- 1.1.4 Xenografts
- 1.1.5 Synthetics
- 1.1.6 Growth Factors
- 1.1.7 Orthopedic Stem Cell Products
- 1.2 Osteoarthritis and Hyaluronic Acid Viscosupplementation Overview
- 1.2.1 Treatment Alternatives
- 1.2.1.1 Nonpharmacologic Treatments
- 1.2.1.2 Nonsteroidal Anti-Inflammatory Drugs
- 1.2.1.3 Cyclooxygenase-2 Inhibitors
- 1.2.1.4 Hyaluronic Acid Viscosupplementation
- 1.3 Knee Cartilage Repair Overview
- 1.3.1 Treatment Alternatives
- 1.3.1.1 Debridement and Microfracture
- 1.3.1.2 Osteochondral Autograft Transplantation
- 1.3.1.3 Osteochondral Allograft Transplantation
- 1.3.1.4 Autologous Chondrocyte Implantation
- 1.3.1.5 Cell-free Technologies
- 1.3.1.6 Synthetic Implants
2.0 EUROPEAN ORTHOPEDIC BIOMATERIAL MARKET
- 2.1 Market Overview
- 2.2 Market Analysis
- 2.2.1 Key Report Updates
- 2.2.2 Procedures
- 2.2.3 Market Forecast
- 2.2.3.1 Bone Graft Substitute Market
- 2.2.3.2 Hyaluronic Acid Viscosupplementation Market
- 2.2.3.3 Knee Cartilage Repair Market
- 2.3 Competitive Analysis
- 2.3.1 Competitive Landscape
- 2.3.2 Market Shares
3.0 BONE GRAFT SUBSTITUTE MARKET
- 3.1 Market Overview
- 3.2 Market Analysis
- 3.2.1 Procedures
- 3.2.1.1 Procedures by Application
- Trauma Surgeries
- Joint Revision and Reconstruction
- Thoracolumbar and Cervical Spinal Fusions
- Craniomaxillofacial Surgeries
- 3.2.1.2 French Bone Graft Procedures
- 3.2.1.3 German Bone Graft Procedures
- 3.2.1.4 Italian Bone Graft Procedures
- 3.2.1.5 Spanish Bone Graft Procedures
- 3.2.1.6 UK Bone Graft Procedures
- 3.2.2 Market Forecast
- 3.2.2.1 French Bone Graft Substitute Market
- 3.2.2.2 German Bone Graft Substitute Market
- 3.2.2.3 Italian Bone Graft Substitute Market
- 3.2.2.4 Spanish Bone Graft Market
- 3.2.2.5 UK Bone Graft Substitute Market
- 3.2.3 Market Drivers and Limiters
- 3.2.3.1 Market Drivers
- 3.2.3.2 Market Limiters
- 3.3 Competitive Analysis
- 3.3.1 Competitive Landscape
- 3.3.2 Market Shares
- 3.3.3 Competitor Discussions (in Alphabetical Order)
- ApaTech (Acquired by Baxter International)
- Biomet
- Bioteck
- DePuy
- Medtronic Spinal & Biologics
- RTI Biologics
- Scient' x
- Stryker
- Synthes
- Other
4.0 HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
- 4.1 Market Overview
- 4.2 Market Analysis
- 4.2.1 Procedures
- 4.2.1.1 French Hyaluronic Acid Viscosupplementation Procedures
- 4.2.1.2 German Hyaluronic Acid Viscosupplementation Procedures
- 4.2.1.3 Italian Hyaluronic Acid Viscosupplementation Procedures
- 4.2.1.4 Spanish Hyaluronic Acid Viscosupplementation Procedures
- 4.2.1.5 UK Hyaluronic Acid Viscosupplementation Procedures
- 4.2.2 Market Forecast
- 4.2.2.1 French Hyaluronic Acid Viscosupplementation Market
- 4.2.2.2 German Hyaluronic Acid Viscosupplementation Market
- 4.2.2.3 Italian Hyaluronic Acid Viscosupplementation Market
- 4.2.2.4 Spanish Hyaluronic Acid Viscosupplementation Market
- 4.2.2.5 UK Hyaluronic Acid Viscosupplementation Market
- 4.2.3 Market Drivers and Limiters
- 4.2.3.1 Market Drivers
- 4.2.3.2 Market Limiters
- 4.3 Competitive Analysis
- 4.3.1 Competitive Landscape
- 4.3.2 Market Shares
- 4.3.3 Competitor Discussions (in Alphabetical Order)
- Anika Therapeutics
- Bioniche Pharma
- Croma-Pharma
- Fidia Farmaceutici
- Genzyme Biosurgery
- Laboratoires Genevrier
- Merckle-Recordati
- Q-Med
- Rottapharm
- Tedec-Meiji Farma
- TRB Chemedica
- Other
5.0 KNEE CARTILAGE REPAIR MARKET
- 5.1 Market Overview
- 5.2 Market Analysis
- 5.2.1 Standardization of Advanced Therapy Medicinal Products in the
European Union
- 5.2.2 Procedures
- 5.2.2.1 Debridement and Microfracture/Debridement Procedures
- 5.2.2.2 Autologous Chondrocyte Implantation Procedures
- 5.2.2.3 Single-step Technology Procedures
- 5.2.2.4 Osteochondral Autograft Procedures
- 5.2.2.5 Osteochondral Allograft Procedures
- 5.2.2.6 Synthetic Implant Procedures
- 5.2.3 Market Forecast
- 5.2.3.1 Market Forecast by Country
- French Knee Cartilage Repair Market
- German Knee Cartilage Repair Market
- Italian Knee Cartilage Repair Market
- Spanish Knee Cartilage Repair Market
- UK Knee Cartilage Repair Market
- 5.2.4 Market Drivers and Limiters
- 5.2.4.1 Market Drivers
- 5.2.4.2 Market Limiters
- 5.3 Competitive Analysis
- 5.3.1 Competitive Landscape
- 5.3.2 Market Shares
- 5.3.3 Competitor Discussions (in Alphabetical Order)
- Arthrex
- B. Braun Aesculap (through TETEC Tissue Engineering Technologies)
- BioTissue Technologies
- co.don
- Fidia Advanced Biopolymers (FAB) (Acquired by Anika Therapeutics)
- Geistlich
- Genzyme
- Smith & Nephew
- Other
- 5.3.3.1 Notable and Emerging Competitors
APPENDIX A: MRG ACRONYMS AND INITIALISMS
APPENDIX B: POPULATION STATISTICS
APPENDIX C: OSTEOARTHRITIS EPIDEMIOLOGY
APPENDIX D: OSTEOPENIA EPIDEMIOLOGY
APPENDIX E: OSTEOPOROSIS EPIDEMIOLOGY
APPENDIX F: AUSTRIAN HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
APPENDIX G: AUSTRIAN KNEE CARTILAGE REPAIR MARKET
APPENDIX H: SUPPLEMENTAL FIGURES
LIST OF FIGURES AND TABLES
TABLE OF CONTENTS
LIST OF FIGURES AND TABLES
EXECUTIVE SUMMARY
- Figure 1: Orthopedic Biomaterial Market, by Segment, Europe (US$), 2009 -
2015
- Figure 2: BGS Procedures, by Material, Europe, 2009 - 2015
- Figure 3: HA Viscosupplementation Market, by Segment, as a % of Total,
Europe, 2010 and 2015
- Figure 4: Knee Cartilage Repair Procedures, by Country, Europe, 2009 - 2015
- Table 1: Companies Mentioned in This Report
METHODOLOGY
- Table 2: Currency Exchange Rates (US$ to Local Currency), 2010
- Table 3: Currency Exchange Rates (€ to Local Currency), 2010
1.0 ORTHOPEDIC BIOMATERIALS BACKGROUND
- Table 4: Characteristics of Bone Graft Materials
- Table 5: Advantages and Disadvantages of Various Bone Graft Materials
- Table 6: Select Synthetic BGS Materials
2.0 EUROPEAN ORTHOPEDIC BIOMATERIAL MARKET
- Figure 5: Orthopedic Biomaterial Market, by Country, Europe (US$), 2009 -
2015
- Table 7: Key Report Changes, 2011
- Table 8: Orthopedic Biomaterial Market, by Country, Europe (US$ and €
), 2009 - 2015
- Table 9: Orthopedic Biomaterial Market, by Segment, Europe (US$ and €
), 2009 - 2015
- Figure 6: Leading Competitors in the Orthopedic Biomaterial Market, as a %
of Total, Europe, 2010
- Table 10: Leading Competitors in the Orthopedic Biomaterial Market, by
Segment, as a % of Total, Europe, 2010
3.0 BONE GRAFT SUBSTITUTE MARKET
- Figure 7: BGS Procedure Growth, by Material, Europe, 2010 - 2015
- Table 11: Average Volume of Bone Graft Used per Procedure, by Application,
Europe, 2010
- Table 12: Bone Graft Procedures, by Material, Europe, 2009 - 2015
- Table 13: Bone Graft Procedures, by Application, Europe, 2009 - 2015
- Table 14: BGS Procedures, by Application, Europe, 2009 - 2015
- Table 15: Bone Graft Procedures, by Material, France, 2009 - 2015
- Table 16: Bone Graft Procedures, by Application, France, 2009 - 2015
- Table 17: BGS Procedures, by Application, France, 2009 - 2015
- Table 18: Bone Graft Procedures, by Material, Germany, 2009 - 2015
- Table 19: Bone Graft Procedures, by Application, Germany, 2009 - 2015
- Table 20: BGS Procedures, by Application, Germany, 2009 - 2015
- Table 21: Bone Graft Procedures, by Material, Italy, 2009 - 2015
- Table 22: Bone Graft Procedures, by Application, Italy, 2009 - 2015
- Table 23: BGS Procedures, by Application, Italy, 2009 - 2015
- Table 24: Bone Graft Procedures, by Material, Spain, 2009 - 2015
- Table 25: Bone Graft Procedures, by Application, Spain, 2009 - 2015
- Table 26: BGS Procedures, by Application, Spain, 2009 - 2015
- Table 27: Bone Graft Procedures, by Material, UK, 2009 - 2015
- Table 28: Bone Graft Procedures, by Application, UK, 2009 - 2015
- Table 29: BGS Procedures, by Application, UK, 2009 - 2015
- Table 30: BGS Market, by Material, Europe (US$ and € ), 2009 - 2015
- Table 31: BGS Market, by Application, Europe (US$ and € ), 2009 - 2015
- Table 32: BGS Market, by Material, France (US$ and € ), 2009 - 2015
- Table 33: BGS ASPs, by Application, France (US$ and € ), 2009 - 2015
- Table 34: BGS Market, by Application, Europe (US$ and € ), 2009 - 2015
- Table 35: BGS Market, by Material, Germany (US$ and € ), 2009 - 2015
- Table 36: BGS ASPs, by Application, Germany (US$ and € ), 2009 - 2015
- Table 37: BGS Market, by Application, Germany (US$ and € ), 2009 -
2015
- Table 38: BGS Market, by Material, Italy (US$ and € ), 2009 - 2015
- Table 39: BGS ASPs, by Application, Italy (US$ and € ), 2009 - 2015
- Table 40: BGS Market, by Application, Italy (US$ and € ), 2009 - 2015
- Table 41: BGS Market, by Material, Spain (US$ and € ), 2009 - 2015
- Table 42: BGS ASPs, by Application, Spain (US$ and € ), 2009 - 2015
- Table 43: BGS Market, by Application, Spain (US$ and € ), 2009 - 2015
- Table 44: BGS Market, by Material, UK (US$, € , and £), 2009 -
2015
- Table 45: BGS ASPs, by Application, UK (US$, € , and £), 2009 -
2015
- Table 46: BGS Market, by Application, UK (US$, € , and £), 2009
- 2015
- Table 47: Drivers and Limiters of the BGS Market, Europe
- Table 48: Leading Competitors in the Bone Graft Substitute Market, as a %
of Total, Europe, 2010
4.0 HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
- Figure 8: HA Viscosupplementation Market, by Segment, Europe (US$), 2009 -
2015
- Table 49: HA Viscosupplementation Treatments and Injections, by Segment,
Europe, 2009 - 2015
- Table 50: HA Viscosupplementation Treatments, by Application, Europe, 2009
- 2015
- Table 51: HA Viscosupplementation Treatments and Injections, by Segment,
France, 2009 - 2015
- Table 52: HA Viscosupplementation Treatments, by Application, France, 2009
- 2015
- Table 53: HA Viscosupplementation Treatments and Injections, by Segment,
Germany, 2009 - 2015
- Table 54: HA Viscosupplementation Treatments, by Application, Germany,
2009 - 2015
- Table 55: HA Viscosupplementation Treatments and Injections, by Segment,
Italy, 2009 - 2015
- Table 56: HA Viscosupplementation Treatments, by Application, Europe,
Italy, 2009 - 2015
- Table 57: HA Viscosupplementation Treatments and Injections, by Segment,
Spain, 2009 - 2015
- Table 58: HA Viscosupplementation Treatments, by Application, Spain, 2009
- 2015
- Table 59: HA Viscosupplementation Treatments and Injections, by Segment,
UK, 2009 - 2015
- Table 60: HA Viscosupplementation Treatments, by Application, UK, 2009 -
2015
- Table 61: HA Viscosupplementation Market, by Segment, Europe (US$), 2009 -
2015
- Table 62: HA Viscosupplementation Market, by Segment, Europe (€ ),
2009 - 2015
- Table 63: HA Viscosupplementation Market Growth, by Segment, Europe, 2010
- 2015
- Table 64: HA Viscosupplementation Market, by Segment, as a % of Total,
Europe, 2009 - 2015
- Table 65: HA Viscosupplementation Market, by Segment, France (US$), 2009 -
2015
- Table 66: HA Viscosupplementation Market, by Segment, France (€ ),
2009 - 2015
- Table 67: HA Viscosupplementation Market Growth, by Segment, France, 2010
- 2015
- Table 68: HA Viscosupplementation Market, by Segment, as a % of Total,
France, 2009 - 2015
- Table 69: HA Viscosupplementation Market, by Segment, Germany, (US$), 2009
- 2015
- Table 70: HA Viscosupplementation Market, by Segment, Germany, (€ ),
2009 - 2015
- Table 71: HA Viscosupplementation Market Growth, by Segment, Germany, 2010
- 2015
- Table 72: HA Viscosupplementation Market, by Segment, as a % of Total,
Germany, 2009 - 2015
- Table 73: HA Viscosupplementation Market, by Segment, Italy (US$), 2009 -
2015
- Table 74: HA Viscosupplementation Market, by Segment, Italy (€ ),
2009 - 2015
- Table 75: HA Viscosupplementation Market Growth, by Segment, Italy, 2010 -
2015
- Table 76: HA Viscosupplementation Market, by Segment, as a % of Total,
Italy, 2009 - 2015
- Table 77: HA Viscosupplementation Market, by Segment, Spain (US$), 2009 -
2015
- Table 78: HA Viscosupplementation Market, by Segment, Spain (€ ),
2009 - 2015
- Table 79: HA Viscosupplementation Market Growth, by Segment, Spain, 2010 -
2015
- Table 80: HA Viscosupplementation Market, by Segment, as a % of Total,
Spain, 2009 - 2015
- Table 81: HA Viscosupplementation Market, by Segment, UK (US$), 2009 - 2015
- Table 82: HA Viscosupplementation Market, by Segment, UK (€ ), 2009 -
2015
- Table 83: HA Viscosupplementation Market, by Segment, UK (£), 2009 -
2015
- Table 84: HA Viscosupplementation Market Growth, by Segment, UK, 2010 -
2015
- Table 85: HA Viscosupplementation Market, by Segment, as a % of Total, UK,
2009 - 2015
- Table 86: Drivers and Limiters of the HA Viscosupplementation Market,
Europe
- Table 87: Leading Competitors in the HA Viscosupplementation Market, by
Country, as a % of Total, Europe, 2010
5.0 KNEE CARTILAGE REPAIR MARKET
- Figure 9: Knee Cartilage Repair Market, by Type, as a % of Total, Europe,
2010 and 2015
- Table 88: Knee Cartilage Repair Procedures, by Country, Europe, 2009 - 2015
- Table 89: Knee Cartilage Repair Procedures, by Type, Europe, 2009 - 2015
- Table 90: Knee Cartilage Repair Procedures, by Type, France, 2009 - 2015
- Table 91: Knee Cartilage Repair Procedures, by Type, Germany, 2009 - 2015
- Table 92: Knee Cartilage Repair Procedures, by Type, Italy, 2009 - 2015
- Table 93: Knee Cartilage Repair Procedures, by Type, Spain, 2009 - 2015
- Table 94: Knee Cartilage Repair Procedures, by Type, UK, 2009 - 2015
- Table 95: Knee Cartilage Repair Market, by Country, Europe (US$), 2009 -
2015
- Table 96: Knee Cartilage Repair Market, by Country, Europe (€ ), 2009
- 2015
- Table 97: Knee Cartilage Repair Market, by Type, Europe (US$), 2009 - 2015
- Table 98: Knee Cartilage Repair Market, by Type, Europe (€ ), 2009 -
2015
- Table 99: Knee Cartilage Repair Market Growth, by Type, Europe, 2010 - 2015
- Table 100: Knee Cartilage Repair Market, by Type, as a % of Total, Europe,
2009 - 2015
- Table 101: Knee Cartilage Repair Market, by Type, France (US$), 2009 - 2015
- Table 102: Knee Cartilage Repair Market, by Type, France (€ ), 2009 -
2015
- Table 103: Knee Cartilage Repair Market Growth, by Type, France, 2010 -
2015
- Table 104: Knee Cartilage Repair Market, by Type, as a % of Total, France,
2009 - 2015
- Table 105: Knee Cartilage Repair Market, by Type, Germany (US$), 2009 -
2015
- Table 106: Knee Cartilage Repair Market, by Type, Germany (€ ), 2009
- 2015
- Table 107: Knee Cartilage Repair Market Growth, by Type, Germany, 2010 -
2015
- Table 108: Knee Cartilage Repair Market, by Type, as a % of Total,
Germany, 2009 - 2015
- Table 109: Knee Cartilage Repair Market, by Type, Italy (US$), 2009 - 2015
- Table 110: Knee Cartilage Repair Market, by Type, Italy (€ ), 2009 -
2015
- Table 111: Knee Cartilage Repair Market Growth, by Type, Italy, 2010 - 2015
- Table 112: Knee Cartilage Repair Market, by Type, as a % of Total, Italy,
2009 - 2015
- Table 113: Knee Cartilage Repair Market, by Type, Spain (US$), 2009 - 2015
- Table 114: Knee Cartilage Repair Market, by Type, Spain (€ ), 2009 -
2015
- Table 115: Knee Cartilage Repair Market Growth, by Type, Spain, 2010 - 2015
- Table 116: Knee Cartilage Repair Market, by Type, as a % of Total, Spain,
2009 - 2015
- Table 117: Knee Cartilage Repair Market, by Type, UK (US$), 2009 - 2015
- Table 118: Knee Cartilage Repair Market, by Type, UK (€ ), 2009 - 2015
- Table 119: Knee Cartilage Repair Market, by Type, UK (£), 2009 - 2015
- Table 120: Knee Cartilage Repair Market Growth, by Type, UK, 2010 - 2015
- Table 121: Knee Cartilage Repair Market, by Type, as a % of Total, UK,
2009 - 2015
- Table 122: Drivers and Limiters of the Knee Cartilage Repair Market, Europe
- Table 123: Leading Competitors in the Knee Cartilage Repair Market, by
Country, as a % of Total, 2009
APPENDIX A: MRG ACRONYMS AND INITIALISMS
- MRG Acronyms and Initialisms
APPENDIX B: POPULATION STATISTICS
- Table 124: Population, by Age, France, 2010 - 2015
- Table 125: Population, by Age, Germany, 2010 - 2015
- Table 126: Population, by Age, Italy, 2010 - 2015
- Table 127: Population, by Age, Spain, 2010 - 2015
- Table 128: Population, by Age, UK, 2010 - 2015
APPENDIX C: OSTEOARTHRITIS EPIDEMIOLOGY
- Table 129: Prevalence of Osteoarthritis, by Age, France, 2010 - 2015
- Table 130: Prevalence of Osteoarthritis, by Age, Germany, 2010 - 2015
- Table 131: Prevalence of Osteoarthritis, by Age, Italy, 2010 - 2015
- Table 132: Prevalence of Osteoarthritis, by Age, Spain, 2010 - 2015
- Table 133: Prevalence of Osteoarthritis, by Age, UK, 2010 - 2015
APPENDIX D: OSTEOPENIA EPIDEMIOLOGY
- Table 134: Prevalence of Osteopenia, by Age, France, 2010 - 2015
- Table 135: Prevalence of Osteopenia, by Age, Germany, 2010 - 2015
- Table 136: Prevalence of Osteopenia, by Age, Italy, 2010 - 2015
- Table 137: Prevalence of Osteopenia, by Age, Spain, 2010 - 2015
- Table 138: Prevalence of Osteopenia, by Age, UK, 2010 - 2015
APPENDIX E: OSTEOPOROSIS EPIDEMIOLOGY
- Table 139: Prevalence of Osteoporosis, by Age, France, 2010 - 2015
- Table 140: Prevalence of Osteoporosis, by Age, Germany, 2010 - 2015
- Table 141: Prevalence of Osteoporosis, by Age, Italy, 2010 - 2015
- Table 142: Prevalence of Osteoporosis, by Age, Spain, 2010 - 2015
- Table 143: Prevalence of Osteoporosis, by Age, UK, 2010 - 2015
APPENDIX F: AUSTRIAN HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
- Table 144: HA Viscosupplementation Treatments and Injections, by Segment,
Austria, 2009 - 2015
- Table 145: HA Viscosupplementation Treatments, by Application, Austria,
2009 - 2015
- Table 146: HA Viscosupplementation Market, by Segment, Austria (US$), 2009
- 2015
- Table 147: HA Viscosupplementation Market, by Segment, Austria (€ ),
2009 - 2015
- Table 148: HA Viscosupplementation Market Growth, by Segment, Austria,
2010 - 2015
- Table 149: HA Viscosupplementation Market, by Segment, as a % of Total,
Austria, 2009 - 2015
APPENDIX G: AUSTRIAN KNEE CARTILAGE REPAIR MARKET
- Table 150: Knee Cartilage Repair Procedures, by Type, Austria, 2009 - 2015
- Table 151: Knee Cartilage Repair Market, by Type, Austria (US$), 2009 -
2015
- Table 152: Knee Cartilage Repair Market, by Type, Austria (€ ), 2009
- 2015
- Table 153: Knee Cartilage Repair Market Growth, by Type, Austria, 2010 -
2015
- Table 154: Knee Cartilage Repair Market, by Type, as a % of Total,
Austria, 2009 - 2015
APPENDIX H: SUPPLEMENTAL FIGURES
- Figure 10: Orthopedic Biomaterial Market, by Segment, Europe (US$), 2009 -
2015 (Detailed Format)
- Figure 11: BGS Procedures, by Material, Europe, 2009 - 2015 (Detailed
Format)
- Figure 12: HA Viscosupplementation Market, by Segment, as a % of Total,
Europe, 2010 and 2015 (Detailed Format)
- Figure 13: Knee Cartilage Repair Procedures, by Country, Europe, 2009 -
2015 (Detailed Format)
|
